BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27373440)

  • 1. Low reversibility of intracellular cAMP accumulation in mouse Leydig tumor cells (MLTC-1) stimulated by human Luteinizing Hormone (hLH) and Chorionic Gonadotropin (hCG).
    Klett D; Meslin P; Relav L; Nguyen TM; Mariot J; Jégot G; Cahoreau C; Combarnous Y
    Mol Cell Endocrinol; 2016 Oct; 434():144-53. PubMed ID: 27373440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of sub-stimulating concentrations of non-human versus human Luteinizing Hormones (LH) or chorionic gonadotropins (CG) on adenylate cyclase activation by forskolin in MLTC cells.
    Nguyen TD; Filliatreau L; Klett D; Combarnous Y
    Gen Comp Endocrinol; 2018 May; 261():23-30. PubMed ID: 29355532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course effects of human recombinant luteinizing hormone on porcine Leydig cell specific differentiated functions.
    Lejeune H; Sanchez P; Chuzel F; Langlois D; Saez JM
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):59-69. PubMed ID: 9863627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the behavior of luteinizing hormones of various species at the rat gonadal cell receptor site.
    Rani CS; Moudgal NR
    Endocrinology; 1985 Feb; 116(2):597-603. PubMed ID: 2981670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of gonadotropin-responsive murine leydig tumor cell line.
    Rebois RV
    J Cell Biol; 1982 Jul; 94(1):70-6. PubMed ID: 6288740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive
    Klett D; Combarnous Y
    Reprod Fertil; 2021 Dec; 2(4):300-307. PubMed ID: 35118407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone can participate in down-regulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells.
    El-Hefnawy T; Huhtaniemi I
    Mol Cell Endocrinol; 1998 Feb; 137(2):127-38. PubMed ID: 9605514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the truncation of luteinizing hormone receptors at the plasma membrane is different in rat and mouse Leydig cells.
    West AP; Cooke BA
    Endocrinology; 1991 Jan; 128(1):363-70. PubMed ID: 1846104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of FSHR negative allosteric modulators on LH/CGR reveals biased antagonism with implications in steroidogenesis.
    Ayoub MA; Yvinec R; Jégot G; Dias JA; Poli SM; Poupon A; Crépieux P; Reiter E
    Mol Cell Endocrinol; 2016 Nov; 436():10-22. PubMed ID: 27424143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deglycosylated human chorionic gonadotropin (hCG) antagonizes hCG stimulation of 3',5'-cyclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors.
    Dunkel L; Jia XC; Nishimori K; Boime I; Hsueh AJ
    Endocrinology; 1993 Feb; 132(2):763-9. PubMed ID: 8381073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does gonadotropin receptor complex have an amplifying role in cAMP/testosterone production in Leydig cells?
    Browne ES; Bhalla VK
    J Androl; 1991; 12(2):132-9. PubMed ID: 1646778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of removal of carboxy-terminal extension from equine luteinizing hormone (LH) beta-subunit on LH and follicle-stimulating hormone receptor-binding activities and LH steroidogenic activity in rat testicular Leydig cells.
    Bousfield GR; Liu WK; Ward DN
    Endocrinology; 1989 Jan; 124(1):379-87. PubMed ID: 2462491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols.
    Nikula H; Talonpoika T; Kaleva M; Toppari J
    Toxicol Appl Pharmacol; 1999 Jun; 157(3):166-73. PubMed ID: 10373400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action.
    Mauduit C; Goddard I; Besset V; Tabone E; Rey C; Gasnier F; Dacheux F; Benahmed M
    Endocrinology; 2001 Jun; 142(6):2509-20. PubMed ID: 11356700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of PMSG and asialo-PMSG on rat Leydig and granulosa cells.
    Moyle WR; Erickson G; Bahl OP; Christakos S; Gutowski J
    Am J Physiol; 1978 Aug; 235(2):E218-26. PubMed ID: 210675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant rat luteinizing hormone; production by Chinese hamster ovary cells, purification and functional characterization.
    Hakola K; Boogaart PV; Mulders J; de Leeuw R; Schoonen W; Heyst JV; Swolfs A; Casteren JV; Huhtaniemi I; Kloosterboer H
    Mol Cell Endocrinol; 1997 Apr; 128(1-2):47-56. PubMed ID: 9140075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.
    Shiraishi K; Ascoli M
    Endocrinology; 2007 Jul; 148(7):3214-25. PubMed ID: 17412805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro.
    Riccetti L; De Pascali F; Gilioli L; Potì F; Giva LB; Marino M; Tagliavini S; Trenti T; Fanelli F; Mezzullo M; Pagotto U; Simoni M; Casarini L
    Reprod Biol Endocrinol; 2017 Jan; 15(1):2. PubMed ID: 28056997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous and pulsatile infusions of luteinizing hormone have identical effects on steroidogenic capacity and sensitivity of Leydig cells in rats passively immunized against gonadotropin-releasing hormone.
    Gibson-Berry KL; Chase DJ
    Endocrinology; 1990 Jun; 126(6):3107-15. PubMed ID: 1693567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.